Latest Stem Cell Therapeuti (SCTPF) Headlines Stem Cell

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Stem Cell Therapeuti (SCTPF) Headlines

Stem Cell Therapeutics Strengthens its Board of Directors
Marketwire - Mon Mar 10, 6:01AM CDT
Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics, today announced that Mr. Luke Beshar and Dr. Thomas Reynolds have been appointed to the Company's Board of Directors.

Stem Cell Therapeutics Announces Appointment of Dr. Calvin R. Stiller as Chairman
Marketwire - Thu Jan 30, 6:38AM CST
Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics, is pleased to announce that its Board of Directors has elected Dr. Calvin R. Stiller as Chairman of the Board. Dr. Stiller has been a member of the Board since July 2011 and served as Lead Director and Chair of the Governance and Nominating Committee.

Stem Cell Therapeutics Announces Resignation of Director
Marketwire - Mon Jan 27, 6:01AM CST
Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics, announces that effective today, Mr. David Allan has resigned from its board of directors.

Stem Cell Therapeutics Provides Corporate Update
Marketwire - Mon Jan 13, 6:01AM CST
Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics, today provided the following six-month corporate update:

Stem Cell Therapeutics Appoints Dr. Robert Kirkman to Its Board of Directors
Marketwire - Tue Dec 17, 6:01AM CST
Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics, today announced that industry veteran Dr. Robert L. Kirkman has been appointed to the Company's Board of Directors.

Stem Cell Therapeutics Completes $33 Million Private Placement
Marketwire - Fri Dec 13, 3:50PM CST
Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), an immuno-oncology company developing cancer stem cell- related therapeutics, is pleased to announce that it has raised gross proceeds of $33 million through a private placement of units. The financing proceeds will be used to advance the Company's CD47 cancer stem cell program through IND-enabling studies, manufacturing and phase 1 clinical trials.

Stem Cell Therapeutics Receives U.S. Orphan Drug Designation for the Use of Tigecycline to Treat Acute Myeloid Leukemia
Marketwire - Thu Oct 31, 6:01AM CDT
Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics, today announced that it has been granted Orphan Drug designation by the U.S. Food and Drug Administration (FDA) for the use of tigecycline in the treatment of acute myeloid leukemia (AML).

Stem Cell Therapeutics Strengthens CD47 Franchise With Acquistion of Complementary Antibody Program
Marketwire - Thu Oct 17, 6:01AM CDT
Stem Cell Ther apeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), a biopharmaceutical immuno-oncology company developing cancer stem cell-related therapeutics, today announced that it has entered into an option agreement to exclusively license worldwide rights to a panel of fully human monoclonal antibodies targeting the SIRPa protein (CD172a). The technology was developed by scientists at the University Health Network, the University of Toronto, through the Toronto Recombinant Antibody Centre (TRAC), and The Hospital for Sick Children (SickKids), in Toronto, Ontario.

Stem Cell Therapeutics Adopts Shareholder Rights Plan
Marketwire - Tue Sep 17, 6:01AM CDT
Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), a biopharmaceutical company developing cancer stem cell-related therapeutics, today announces that it has adopted a shareholder rights plan (the "Plan") effective September 16, 2013. The Company will be seeking shareholder approval of the Plan at its next annual general and special meeting of shareholders.

Stem Cell Therapeutics Advances CD47 Antagonist Program Into IND-Enabling Phase
Marketwire - Mon Sep 09, 6:01AM CDT
Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), a biopharmaceutical company developing cancer stem cell- related therapeutics, today announced that it has advanced its CD47 antagonist program into an Investigational New Drug (IND) enabling phase. In collaboration with a contract manufacturing organization, Stem Cell Therapeutics (SCT) will begin the manufacturing process to generate drug for formal toxicology studies and a subsequent phase I clinical study, which is anticipated to begin in H2/2015.

Trillium Therapeutics Inc. (TRIL) Stock Research Links

TRIL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Connected Retail Security: Rising Risks and Fragmented Roles

Updated Category News Views 4

Cyber Threats in the Connected Retail Landscape The retail world isn't what it used to be. Walk into a store today, and you're greeted not just by products but a web of interconnected systems screaming for attention. Sure, you've got your old-school POS systems humming along, but they're just one brittle cog in a rattling machine of IoT devices, cloud platforms, and...

Continue Reading
USF Law Innovators: Leading AI Integration in Academics

Updated Category News Views 2

Revolutionizing Legal Academia with AI If there's one thing that's caught my eye in the realm of education, it's how some folks over at the University of San Francisco School of Law are shaking things up. These legal eagles aren't messing around with the usual, archaic ways of teaching the law. Nope, they've dove headfirst into the future by hooking their curriculum to...

Continue Reading
Dimerix Locks Down A$34M Loan: No Shareholder Dilution

Updated Category News Views 0

Dimerix Grabs Non-Dilutive Funds amid Kidney Trials Here we go with Dimerix's latest move, folks. They roped in A$34 million through a cozy get-together with lenders from Australia and the U.S. What's the kicker? This cash won't touch shareholder equity. So, breathe easy, investors. It's a rare feat to pull off non-dilutive funds these days, especially in the biopharma...

Continue Reading
Russo-Rodriguez: A New Era in Florida Politics?

Updated Category News Views 5

A Political Shake-Up in Florida On a seemingly regular day in New Smyrna Beach, Frank Russo, the independent candidate for governor, decided to toss a wrench into Florida's political machine. By naming Rachel Rodriguez as his running mate, he's forging a new path that challenges entrenched party norms. This Russo-Rodriguez ticket is stirring the political pot,...

Continue Reading
Mental Health Lab Aims to Boost Workforce Resilience

Updated Category News Views 9

Redefining Workforce Mental Health It’s about time someone shook up how we tackle workforce mental health. Enter Project Healthy Minds and their newly minted Workforce Lab, roping in some of the big dogs like Acast, KPMG, and L'Oréal USA. They've tagged Harvard Business School gurus to churn out data on what helps—or harms—workplace sanity. Finally, a chance to put...

Continue Reading
Aristocrat's Tiki Fire Slots Heat Up North America

Updated Category News Views 1

The Polynesian Flame Ignites: Tiki Fire Hits Online Games Just when you thought the iGaming world was catching its breath, Aristocrat Interactive throws another curveball. The buzz around their Lightning Link™ series, especially the launch of High Stakes™ in July, took the scene by storm. Now, just in time for another sizzle, they've rolled out Tiki Fire™, bringing...

Continue Reading
Curve Memberships: A New Path for Dental Practices

Updated Category News Views 2

Revolutionizing Dental Practice Management Ever met a dentist who says they love dealing with insurance bureaucracies? Yeah, me neither. Curve Dental's latest gambit into membership plans is aiming to slice right through that mess. They've launched a shiny new component aptly named Curve Memberships. This isn't just some fly-by-night addon; it's about deep...

Continue Reading
October 15 Marks Prologis Q3 2026 Results Call

Updated Category News Views 2

Prologis Steps Up to the Plate This October If you’ve got a finger in any logistic pies, make sure it's wrapped around the latest from Prologis come October 15. The logistics behemoth is rolling out the red carpet for its third quarter results, with all eyes on what their senior management will spill. Frankly, you don’t just show up to these things to sip coffee and...

Continue Reading
UGREEN's MagFlow Series: A Game-Changer in Charging

Updated Category News Views 1

UGREEN Unveils a Cool Revolution in Charging Out in Foxborough, UGREEN is shaking things up at its Smart Living Launch Event. The big reveal? The MagFlow Series, their flagship wireless charging lineup, which promises faster and cooler charging than ever before. UGREEN's taking wireless charging to new heights, and that's got my attention. What Makes MagFlow Stand Out...

Continue Reading
King Risk Partners Expands Mid-Atlantic Presence Boldly

Updated Category News Views 1

King Risk Partners Grows with New Jersey Acquisition You don't get far in the insurance game without making some bold moves, and King Risk Partners just made a big one—sweeping into New Jersey. They've snagged Conover Beyer Associates Insurance, a firm that's been around longer than some European countries. It's not every day you buy a piece of history, but that's...

Continue Reading

Top 5 Most Recently Viewed Articles

Pacific Petroleum Strengthens Position with Strategic Acquisition

Updated Category News Views 733

Pacific Petroleum Completes Acquisition of U.S. Oil & Gas Assets Pacific Petroleum Operating, LLC ("Pacific Petroleum"), an investment associated with Pacific Bays Capital, has successfully completed its acquisition of a valuable portfolio of oil-producing assets. Partnering with VCP Operating, LLC, this acquisition marks an important milestone in enhancing the company's...

Continue Reading
Motorola Solutions Enhances Emergency Services with 3tc Software

Updated Category News Views 26

Motorola Solutions Acquires 3tc Software for Enhanced Emergency Services Motorola Solutions, Inc. (NYSE: MSI) has made a significant move by acquiring 3tc Software, a reputable provider of control room software tailored for Fire and Rescue Services as well as Police departments. This strategic acquisition marks a new chapter in Motorola’s commitment to enhancing the...

Continue Reading
Wheels Up Strengthens Aviation Services Through New Modernization Moves

Updated Category News Views 113

Wheels Up Strengthens Aviation Services Through New Modernization Moves Wheels Up Experience Inc. (NYSE: UP), a pioneering figure in on-demand private aviation, is taking significant steps forward with its fleet transformation strategy. Recently, the company engaged in a strategic sale-leaseback transaction, which involves a selection of the Phenom and Challenger...

Continue Reading
Children’s Place Reports Significant Results and Strategies Ahead

Updated Category News Views 283

Strong Performance in the Fourth Quarter The Children’s Place, Inc. (Nasdaq: PLCE), recognized as North America's leading children's specialty retailer, has reported remarkable progress in its financial performance for the fourth quarter. The company achieved net sales totaling $409 million for this quarter, along with a total of $1.386 billion for the entire fiscal...

Continue Reading
Willdan Group Hits New 52-Week High as Market Confidence Grows

Updated Category News Views 52

Willdan Group Reaches Stock Milestone Willdan Group Inc. (NASDAQ: WLDN) recently achieved an impressive milestone as its stock rose to a 52-week high of $40.62. This accomplishment reflects the growing confidence investors have in the company's future. Over the past year, Willdan Group has attracted considerable support from investors, which has led to an incredible 95.4%...

Continue Reading